Published in Arch Pathol Lab Med on February 01, 1993
The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J Infect Dis (2005) 2.02
Effect of multiple freeze-thaw cycles on hepatitis B virus DNA and hepatitis C virus RNA quantification as measured with branched-DNA technology. J Clin Microbiol (1999) 0.90
Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time. J Clin Microbiol (2002) 0.85
Detection of hepatitis C virus by PCR in second-generation enzyme immunoassay-seropositive blood donors by using matched pairs of fresh frozen plasma and pilot tube sera. J Clin Microbiol (1996) 0.82
Lack of protective immunity against reinfection with hepatitis C virus. Science (1992) 4.94
Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature (1987) 4.52
Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol (1998) 3.73
Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A (1994) 3.56
Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol (1988) 3.11
A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta. J Virol (1988) 2.99
Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. Proc Natl Acad Sci U S A (2000) 2.70
Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst (1990) 2.23
Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J Virol (1990) 2.17
Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J (2001) 2.03
Epidemiology of hepatocellular carcinoma. Can J Gastroenterol (2000) 1.80
Fulminant B viral hepatitis: role of delta agent. Gastroenterology (1984) 1.74
Prevalence of delta-antibody among chronic hepatitis B virus infected patients in the Los Angeles area: its correlation with liver biopsy diagnosis. Gastroenterology (1983) 1.70
The adaptive evolution database (TAED). Genome Biol (2001) 1.62
NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection. J Immunol (2000) 1.60
Recombinant hepatitis E virus genomes infectious for primates: importance of capping and discovery of a cis-reactive element. Proc Natl Acad Sci U S A (2001) 1.54
Variation in course of hepatitis E in experimentally infected cynomolgus monkeys. J Infect Dis (1993) 1.52
Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst (1991) 1.50
Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV. Hepatology (2000) 1.49
Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol (1997) 1.39
Experimental infection of chimpanzees with hepatitis C virus of genotype 5a: genetic analysis of the virus and generation of a standardized challenge pool. J Infect Dis (1998) 1.38
Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A (1994) 1.38
Hepatitis C antibodies in patients with alcoholic liver disease commonly have an identifiable risk factor. J Clin Gastroenterol (1992) 1.38
Primary hepatocellular carcinoma following perinatal transmission of hepatitis B. West J Med (1988) 1.38
Host range studies of GB virus-B hepatitis agent, the closest relative of hepatitis C virus, in New World monkeys and chimpanzees. J Med Virol (2001) 1.37
Experimental transmission of hepatitis C virus-associated fulminant hepatitis to a chimpanzee. J Infect Dis (1999) 1.35
cDNA clone of hepatitis A virus encoding a virulent virus: induction of viral hepatitis by direct nucleic acid transfection of marmosets. J Virol (1992) 1.33
A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China. Int J Cancer (1995) 1.26
Hepatitis C virus-associated fulminant hepatic failure. N Engl J Med (1996) 1.23
Heterogeneity of hepatitis delta antigen. Virology (1990) 1.23
Piperazinediium dioxamate. Acta Crystallogr Sect E Struct Rep Online (2009) 1.21
Improved detection of hepatitis C virus antibodies in high-risk populations. Hepatology (1992) 1.18
Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. J Infect Dis (2000) 1.18
Molecular cloning and characterization of an isolate of hepatitis delta virus from Taiwan. Hepatology (1991) 1.17
Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA. J Viral Hepat (1999) 1.16
Advances in directed protein evolution by recursive genetic recombination: applications to therapeutic proteins. Curr Opin Biotechnol (2001) 1.14
A double-blinded, randomized trial of hydrocortisone in acute hepatic failure. The Acute Hepatic Failure Study Group. Dig Dis Sci (1991) 1.13
Functional inferences from reconstructed evolutionary biology involving rectified databases--an evolutionarily grounded approach to functional genomics. Res Microbiol (2000) 1.13
Evolution of hepatitis delta virus RNA during chronic infection. Virology (1992) 1.13
Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study. Br J Cancer (2011) 1.10
Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology (1994) 1.09
Fas-mediated apoptosis causes elimination of virus-specific cytotoxic T cells in the virus-infected liver. J Immunol (2001) 1.07
Hydatid cyst of the cardiac interventricular septum: report of two cases. Br J Radiol (2007) 1.06
Experimental infection of chimpanzees with hepatitis G virus and genetic analysis of the virus. J Infect Dis (1998) 1.06
Epidemic non-A, non-B hepatitis in patients from Pakistan. Ann Intern Med (1987) 1.03
The bile duct adenoma. A lesion distinct from Meyenburg complex. Arch Pathol Lab Med (1984) 1.03
Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells. Vaccine (2001) 1.02
Effects of tumor necrosis factor-alpha and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells. J Investig Med (1996) 1.02
Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. Vaccine (1997) 1.01
Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees. Vaccine (1992) 1.00
Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California. Hepatology (1997) 0.99
Natural course of delta superinfection in chronic hepatitis B virus-infected patients: histopathologic study with multiple liver biopsies. Hepatology (1986) 0.99
Correlation of serum delta RNA with clinical course of acute hepatitis delta virus superinfection in Taiwan: a longitudinal study. J Infect Dis (1990) 0.99
Failure to infect rhesus monkeys with hepatitis C virus strains of genotypes 1a, 2a or 3a. J Viral Hepat (2001) 0.99
Transgenic mice support replication of hepatitis delta virus RNA in multiple tissues, particularly in skeletal muscle. J Virol (1995) 0.99
Immunohistochemical localization of the delta antigen associated with hepatitis B virus in liver biopsy sections embedded in Araldite. Histopathology (1984) 0.98
Delta agent superinfection. Rapidly progressive liver disease in a hepatitis B virus carrier. Arch Pathol Lab Med (1985) 0.96
Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin. J Viral Hepat (2008) 0.95
Prevalence of hepatitis B-associated delta agent among mentally retarded carriers of HBsAg. J Infect Dis (1985) 0.95
Prevalence of hepatitis delta (delta) virus infection. A seroepidemiologic study. West J Med (1988) 0.94
Pathologic features of the liver in acquired immune deficiency syndrome (AIDS). Liver (1986) 0.94
Spontaneous reactivation in chronic hepatitis B: patterns and natural history. J Clin Gastroenterol (1990) 0.93
Blood group antigens in the intrahepatic biliary tree. II. Type 1 chain N-acetyllactosamine-related carbohydrate antigens in the proliferated bile ductules. J Hepatol (1989) 0.93
Experience with human immunodeficiency virus infection in patients with hepatitis B virus and hepatitis delta virus infections in Los Angeles, 1977-1985. Am J Epidemiol (1988) 0.93
Hepatocellular carcinoma in a case of Wilson's disease. Liver (1992) 0.93
A simian strain of hepatitis A virus, AGM-27, functions as an attenuated vaccine for chimpanzees. J Infect Dis (1996) 0.93
Utilization of chimeras between human (HM-175) and simian (AGM-27) strains of hepatitis A virus to study the molecular basis of virulence. J Virol (1998) 0.92
Possible case of HBV-2 infection. Lancet (1988) 0.92
Amino-guanidinium hydrogen succinate. Acta Crystallogr Sect E Struct Rep Online (2009) 0.91
Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County. Am J Gastroenterol (2001) 0.91
Relapse of acute B viral hepatitis--role of delta agent. Gut (1986) 0.91
Replication of hepatitis delta virus RNA in mice after intramuscular injection of plasmid DNA. J Virol (1995) 0.90
Histological benefits of virological response to peginterferon alfa-2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis. Aliment Pharmacol Ther (2008) 0.90
Lack of association between hepatitis C infection and development of AIDS-related lymphoma. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.89
Experimental transmission of the delta virus to a hepatitis B chronic carrier chimpanzee with the development of persistent delta carriage. Am J Pathol (1986) 0.88
Study of preneoplastic changes of liver cells by immunohistochemical and molecular hybridization techniques. Arch Pathol Lab Med (1990) 0.88
Delta hepatitis in the Los Angeles area: a report of 126 cases. Ann Intern Med (1986) 0.87
Intrahepatic lymphocyte phenotypes in hepatitis C virus infection: a comparison between cirrhotic and non-cirrhotic livers. Minerva Gastroenterol Dietol (2007) 0.87
Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees. Hepatology (1999) 0.87
Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B. Cancer (1990) 0.86
alpha-1-Antitrypsin phenotypes in hepatocellular carcinoma. Hepatology (1982) 0.86
Nonpercutaneous spread of delta infection. J Infect Dis (1985) 0.85
Fas- and tumor necrosis factor receptor 1-dependent but not perforin-dependent pathways cause injury in livers infected with an adenovirus construct in mice. Hepatology (2000) 0.85
Spontaneous reactivation of hepatitis B in Chinese patients with HBsAg-positive chronic active hepatitis. Hepatology (1987) 0.85
Correlation of IgM anti-hepatitis D virus (HDV) to HDV RNA in sera of chronic HDV. Hepatology (1989) 0.84
Hepatic inflammation, hepatitis B replication, and cellular immune function in homosexual males with chronic hepatitis B and antibody to human immunodeficiency virus. Am J Gastroenterol (1988) 0.84
Genomic hsd-Mu(lac) operon fusion mutants of Escherichia coli K-12. Gene (1991) 0.84
Progress toward the development of a genetically engineered attenuated hepatitis A virus vaccine. J Virol (1996) 0.83
Pathologic and ultrastructural changes of acute and chronic delta hepatitis in an experimentally infected chimpanzee. Am J Pathol (1986) 0.83
Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. Hepatology (1994) 0.83
Extracellular nicotinamide adenine dinucleotide induces t cell apoptosis in vivo and in vitro. J Immunol (2001) 0.83
Low prevalence of hepatitis C infection in hepatocellular carcinoma (HCC) cases and population controls in Guangxi, a hyperendemic region for HCC in the People's Republic of China. Br J Cancer (1996) 0.82